Physician profile
Raymonda Ryce
NPI 1578746665
$2,705.68
in general payments reported to CMS, 2019-2025
28 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $232 · 2021: $730 · 2022: $534 · 2023: $291 · 2024: $378 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,160.42 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Myovant Sciences INC. | $212.22 | 2021-2022 | |
| Lupin INC. | $151.57 | 2019-2021 | |
| Coopersurgical, INC. | $137.40 | 2020-2025 | Paragard T 380a, Ally II Ups |
| Sumitomo Pharma America, INC. | $133.81 | 2023-2024 | Myfembree |
| Organon LLC | $116.59 | 2021-2025 | Nexplanon, Nuvaring |
| Novo Nordisk INC | $98.58 | 2019-2025 | Wegovy |
| Mylan Pharmaceuticals INC. | $83.66 | 2019-2021 | |
| Biogen, INC. | $77.34 | 2024-2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $70.04 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Shield Therapeutics INC | $65.59 | 2022-2023 | Accrufer |
| Hologic Sales and Service, LLC | $64.33 | 2021-2024 | Aptima, Acessa Provu System |
| Amgen INC. | $36.72 | 2022-2023 | Prolia |
| Pfizer INC. | $30.44 | 2021-2025 | |
| Agile Therapeutics, INC. | $28.11 | 2021-2023 | Twirla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $27.05 | 2020-2021 | |
| Davol INC. | $25.50 | 2023 | Arista Ah Flexitip |
| Daiichi Sankyo INC. | $25.49 | 2024 | Injectafer |
| Merck Sharp & Dohme LLC | $21.56 | 2020 | |
| Lilly USA, LLC | $19.22 | 2025 | Zepbound |
| Avion Pharmaceuticals | $17.61 | 2021 | |
| Aspira Women'S Health INC | $16.51 | 2022 | |
| Evofem Biosciences, INC. | $16.08 | 2021 | |
| Ethicon US, LLC | $15.53 | 2022 | |
| Mayne Pharma Commercial LLC | $15.34 | 2025 | |
| Amag Pharmaceuticals, INC. | $14.40 | 2019 | |
| Meditrina | $12.39 | 2022 | |
| Covidien LP | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymonda Ryce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.